Cercar

01/09/2021 Brain aging in major depressive disorder: results from the ENIGMA major depressive disorder working group
Han, LKM, Dinga, R, Hahn, T, Ching, CRK, Eyler, LT, Aftanas, L, Aghajani, M, Aleman, A, Baune, BT, Berger, K, Brak, I, Filho, GB, Carballedo, A, Connolly, CG, Couvy-Duchesne, B, Cullen, KR, Dannlowski, U, Davey, CG, Dima, D, Duran, FLS, Enneking, V, Filimonova, E, Frenzel, S, Frodl, T, Fu, CHY, Godlewska, BR, Gotlib, IH, Grabe, HJ, Groenewold, NA, Grotegerd, D, Gruber, O, Hall, GB, Harrison, BJ, Hatton, SN, Hermesdorf, M, Hickie, IB, Ho, TC, Hosten, N, Jansen, A, Kahler, C, Kircher, T, Klimes-Dougan, B, Kramer, B, Krug, A, Lagopoulos, J, Leenings, R, MacMaster, FP, MacQueen, G, McIntosh, A, McLellan, Q, McMahon, KL, Medland, SE, Mueller, BA, Mwangi, B, Osipov, E, Portella, MJ, Pozzi, E, Reneman, L, Repple, J, Rosa, PGP, Sacchet, MD, Samann, PG, Schnell, K, Schrantee, A, Simulionyte, E, Soares, JC, Sommer, J, Stein, DJ, Steinstrater, O, Strike, LT, Thomopoulos, IT, van Tol, MJ, Veer, IM, Vermeiren, RRJM, Walter, H, van der Wee, NJA, van der Werff, SJA, Whalley, H, Winter, NR, Wittfeld, K, Wright, MJ, Wu, MJ, Volzke, H, Yang, TT, Zannias, V, de Zubicaray, GI, Zunta-Soares, GB, Abe, C, Alda, M, Andreassen, OA, Boen, E, Bonnin, CM, Canales-Rodriguez, EJ, Cannon, D, Caseras, X, Chaim-Avancini, TM, Elvsashagen, T, Favre, P, Foley, SF, Fullerton, JM, Goikolea, JM, Haarman, BCM, Hajek, T, Henry, C, Houenou, J, Howells, FM, Ingvar, M, Kuplicki, R, Lafer, B, Landen, M, Machado-Vieira, R, Malt, UF, McDonald, C, Mitchell, PB, Nabulsi, L, Otaduy, MCG, Overs, BJ, Polosan, M, Pomarol-Clotet, E, Radua, J, Rive, MM, Roberts, G, Ruhe, HG, Salvador, R, Sarro, S, Theodore, DS, Savitz, J, Schene, AH, Schofield, PR, Serpa, MH, Sim, K, Soeiro-de-Souza, MG, Sutherland, AN, Temmingh, HS, Timmons, GM, Uhlmann, A, Vieta, E, Wolf, DH, Zanetti, MV, Jahanshad, N, Thompson, PM, Veltman, DJ, Penninx, BWJH, Marquand, AF, Cole, JH, Schmaal, L. Brain aging in major depressive disorder: results from the ENIGMA major depressive disorder working group. MOLECULAR PSYCHIATRY. 2021; 26(9)DOI:10.1038/s41380-020-0754-0. PMID:32424236. IF:13.437(Q1/1D).
01/12/2025 Could intranasal oxytocin enhance the effects of psychotherapy in individuals with mental disorders? A systematic review and meta-analysis (vol 171, 107206 , 2025)
Arqueros, M, Soler, J, Schmidt, C, Vega, D, Pascual, JC. Could intranasal oxytocin enhance the effects of psychotherapy in individuals with mental disorders? A systematic review and meta-analysis (vol 171, 107206 , 2025). PSYCHONEUROENDOCRINOLOGY. 2025; 182DOI:10.1016/j.psyneuen.2025.107623. PMID:41061382. IF:3.600(Q1/3D).
01/12/2025 Sex-based differences in neurocognitive functioning in first-episode psychosis: An exploratory analysis
Verdaguer-Rodríguez, M, López-Carrilero, R, Díaz-Cutraro, L, Ferrer-Quintero, M, Grasa, E, Pousa, E, Lorente-Rovira, E, Birulés, I, Peláez, T, Barrigón, ML, Ruiz-Delgado, I, González-Higueras, F, Cid, J, Gutiérrez-Zotes, A, Barajas, A, Ochoa, S. Sex-based differences in neurocognitive functioning in first-episode psychosis: An exploratory analysis. PSYCHIATRY RESEARCH. 2025; 354DOI:10.1016/j.psychres.2025.116803. PMID:41167092. IF:3.900(Q1/2D).
01/12/2025 Regional brain morphology and current antidepressant use: findings from 32 international cohorts from the ENIGMA major depressive disorder working group
Serrarens, C, Toenders, YJ, Pozzi, E, Aleman, A, Alexander, N, Basgöze, Z, Belov, V, Berger, K, Brosch, K, Bülow, R, Busatto, GF, Capitao, LP, Connolly, CG, Couvy-Duchesne, B, Cullen, KR, Dannlowski, U, Davey, CG, De Zubicaray, GI, Dima, D, Dohm, K, Enneking, V, Erwin-Grabner, T, Evermann, U, Fu, CHY, Fuentes-Claramonte, P, Godlewska, BR, Gonul, AS, Gotlib, IH, Goya-Maldonado, R, Grabe, HJ, Groenewold, NA, Grotegerd, D, Gruber, O, Hahn, T, Hall, G, Harrison, B, Heindel, W, Hermesdorf, M, Ho, TC, Ichikawa, N, Itai, E, Jahanshad, N, Jamalabadi, H, Jamieson, AJ, Jansen, A, Kircher, T, Klimes-Dougan, B, Krämer, B, Krug, A, Lancaster, TM, Leehr, EJ, Li, M, Linden, DEJ, MacMaster, F, McMahon, KL, Medland, SE, Mehler, DMA, Meinert, S, Mwangi, B, Nenadic, I, Okada, G, Okamoto, Y, Opel, N, Pfarr, JK, Pomarol-Clotet, E, Portella, MJ, Redlich, R, Reneman, L, Repple, J, Ringwald, K, Rodriguez-Cano, E, Rosa, PGP, Sacchet, MD, Sämann, PG, Salvador, R, Schrantee, A, Shinzato, H, Sim, K, Simulionyte, E, Soares, JC, Stein, DJ, Stein, F, Straube, B, Strike, LT, Thomas-Odenthal, F, Thomopoulos, SI, Thompson, PM, Van Tol, MJ, Usemann, P, Uyar, A, van der Wee, N, van der Werff, S, Vives-Gilabert, Y, Völzke, H, Walter, M, Whittle, S, Wittfeld, K, Wroblewski, A, Wu, MJ, Yang, TT, Zunta-Soares, GB, Veltman, DJ, Schmaal, L, van Velzen, LS. Regional brain morphology and current antidepressant use: findings from 32 international cohorts from the ENIGMA major depressive disorder working group. MOLECULAR PSYCHIATRY. 2025; 30(12)DOI:10.1038/s41380-025-03310-8. PMID:41184571. IF:10.100(Q1/1D).
10/11/2025 The Role of Sex, Quality of Life, Self-Esteem and Cognitive Insight in Reducing Personal Stigma in Psychosis
Lamarca, M, Romero-Castillejo, A, Balsells-Mejia, S, Lopez-Carrilero, R, Vila-Badia, R, Pousa, E, Grasa, E, Barrigon, M, Birulés, I, Peláez, T, Gutiérrez-Zotes, A, Cabezas, A, Lorente-Rovira, E, Cid, J, Ruiz-Delgado, I, González-Higueras, F, Legido, T, Moreno-Küstner, B, Barajas, A, Ochoa, S. The Role of Sex, Quality of Life, Self-Esteem and Cognitive Insight in Reducing Personal Stigma in Psychosis. CLINICAL PSYCHOLOGY & PSYCHOTHERAPY. 2025; 32(6)DOI:10.1002/cpp.70171. PMID:41215569. IF:2.700(Q2/3D).
01/11/2025 The Influence of Metacognition, Social Cognition, Self-Esteem, and Quality of Life on Personal Stigma in First-Episode Psychosis
Romero-Castillejo, A, López-Carrilero, R, Vila-Badia, R, Lamarca, M, Pousa, E, Grasa, E, Barajas, A, Barrigon, ML, Birules, I, Peláez, T, Gutiérrez-Zotes, A, Lorente-Rovira, E, Cid, J, Ruiz-Delgado, I, Gonzalez-Higueras, F, Legido, T, Moreno-Küstner, B, Moritz, S, Ochoa, S. The Influence of Metacognition, Social Cognition, Self-Esteem, and Quality of Life on Personal Stigma in First-Episode Psychosis. Stigma And Health. 2025; 10(4)DOI:10.1037/sah0000513. PMID:. IF:(Q/D).
01/11/2025 Polygenic risk score of glycemic homeostasis, Type 2 Diabetes Mellitus and glycemic components in first episode psychosis
Segura, AG, Verdolini, N, Valli, I, Garcia-Rizo, C, Diaz-Caneja, CM, Vieta, E, Mezquida, G, Lobo, A, Gonzalez-Pinto, A, Andreu-Bernabeu, A, Roldan, A, Martinez-Aran, A, Baeza, I, Mane, A, Labad, J, Müller, DJ, Guasch-Capella, N, Bernardo, M, Mas, S, Bioque, GM, Gonzalez, J, Andrés, P, Cavone, V, Corripio, I, Duque, A, Mar-Barrutia, L, Marin, J, De-la-Camara, C, Vaquero-Puyuelo, D, Rivero, O, Fabra, MJE, Trabsa, A, Legido, T, Forte, MF, Serra-Navarro, M, de la Serna, H, Castro-Fornielles, J, Contreras, F, García-Portilla, MP, González-Blanco, L, Echevarría, RS, Rabadán, AZ, Rodriguez-Jimenez, R, Martínez-Gras, I, Usall, J, Barajas, A, Sarro, S, Pomarol-Clotet, E, Ibañez, A, Cuesta, MJ. Polygenic risk score of glycemic homeostasis, Type 2 Diabetes Mellitus and glycemic components in first episode psychosis. SCHIZOPHRENIA RESEARCH. 2025; 285DOI:10.1016/j.schres.2025.09.019. PMID:41075679. IF:3.500(Q1/3D).
01/11/2025 The DEPRE'5 study: pragmatic, multicentre, five-arm, parallel-group randomised controlled trial with blinded assessment to compare treatment strategies in major depression after a failed selective serotonin reuptake inhibitor treatment
Pérez, V, Puigdemont, D, de Diego-Adeliño, J, Elices, M, Leal, I, Cabello, M, Rodriguez-Jimenez, R, Alvarez-Mon, MA, García-Fernández, L, García-Iturrospe, EJA, Escartí, MJ, Montejo, AL, Montes, JM, Usall, J, Gallego-Nogueras, A, Lujan, E, López-Carrilero, R, González-Pinto, A, Ortiz-Jauregui, A, Blanch, J, Urretavizcaya, M, Colom, F, García-Campayo, J, Ayuso-Mateos, JL. The DEPRE'5 study: pragmatic, multicentre, five-arm, parallel-group randomised controlled trial with blinded assessment to compare treatment strategies in major depression after a failed selective serotonin reuptake inhibitor treatment. BRITISH JOURNAL OF PSYCHIATRY. 2025; 227(5)DOI:10.1192/bjp.2025.13. PMID:40530754. IF:7.600(Q1/1D).